Integrative Training in Therapeutic Discovery

治疗发现的综合培训

基本信息

  • 批准号:
    7293594
  • 负责人:
  • 金额:
    $ 34.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-30 至 2010-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Understanding of the mechanisms of human disease is expanding at an exponential rate and the NIH Roadmap is challenging scientists to transform this knowledge into tangible health benefits for people. As a result, teams of academic investigators are formulating therapeutic hypotheses and generating the tools with which to test them. This is creating a heed for individuals with interdisciplinary training in translational medicine and chemical biology. Experience at Vanderbilt has identified a mechanism for training graduate students and postdoctoral/fellows in which they are co-mentored by physician-scientists and chemical biologists. The current application formalizes this experience into a program that will provide integrative training in therapeutic discovery. Its goal is to train graduate students and postdoctoral/fellows in the critical steps of therapeutic discovery, including identifying an unmet medical need, considering the molecular basis of the relevant disease, framing a hypothesis for a novel therapeutic approach,- and generating the lead molecules with which to test the hypothesis. Students will be recruited into the program following their first year in graduate school and postdoctoral will be recruited directly into the program. All students and postdocs will take two courses, Foundations of Chemical Biology and Therapeutic Discovery, as well as seminars in chemical biology and clinical pharmacology. The Therapeutic Discovery.course will provide introductory training in drug discovery and describe case studies in the application of an integrative approach to the discovery of new therapeutic strategies and agents. Guest lecturers will participate in the course to highlight the latest advances in disease treatment from the perspective of the individuals who made them. A community of trainees will be developed by participation in a web-based dialog among teams in both core courses, a weekly journal club, a monthly working group, and an annual retreat. Trainees will organize a symposium of extramural speakers as part of the annual retreat. Trainees will be co-mentored by individuals with expertise in translational medicine and chemical biology and their progress will be closely monitored by the Scientific Advisory Committee of the Training Program. The quality of the training provided will be evaluated annually by both an Internal Advisory Committee and an External Advisory Committee. Substantial investments in faculty recruiting and infrastructure coupled with extensive interactions between the College of Arts and Science and the School of Medicine provides a rich environment for integrative training in therapeutic discovery at Vanderbilt.
描述(由申请人提供):对人类疾病机制的理解正在以指数级的速度扩展,而NIH路线图挑战科学家将这些知识转变为对人们的切实健康益处的挑战。结果,学术研究人员团队正在制定治疗假设,并生成对其进行测试的工具。这正在为接受转化医学和化学生物学方面的跨学科培训的人留意。范德比尔特(Vanderbilt)的经验已经确定了一种培训研究生和博士后/研究员的机制,他们由医师科学家和化学生物学家共同授予。当前的应用程序将这种经验正式化为一个计划,该计划将在治疗发现方面提供综合培训。它的目标是在治疗发现的关键步骤中培训研究生和博士后/研究员,包括确定未满足的医学需求,考虑到相关疾病的分子基础,为新型治疗方法构建假设,并产生铅分子,以测试该假设。在研究生院的第一年后,学生将被招募到该计划中,而博士后将直接招募到该计划中。所有学生和博士后都将参加两门课程:化学生物学和治疗发现的基础,以及化学生物学和临床药理学研讨会。治疗发现。课程将在药物发现中提供介绍性培训,并描述综合方法在发现新的治疗策略和药物中的应用中。客座讲师将参加该课程,以从制造他们的个人的角度强调疾病治疗方面的最新进展。通过参加两个核心课程,每周期刊俱乐部,一个每月工作组和年度静修会的团队之间的基于Web的对话,将开发一个学员社区。作为年度务虚会的一部分,学员将组织校外扬声器的研讨会。学员将由具有转化医学和化学生物学专业知识的个人共同授予,他们的进步将由培训计划的科学咨询委员会密切监视。所提供的培训质量将由内部咨询委员会和外部咨询委员会每年评估。在教师招聘和基础设施方面进行的大量投资,加上艺术与科学学院和医学学院之间的广泛互动,为范德比尔特的治疗发现方面的综合培训提供了丰富的环境。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAWRENCE J. MARNETT其他文献

LAWRENCE J. MARNETT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAWRENCE J. MARNETT', 18)}}的其他基金

Acquisition of an AB Sciex Qtrap 6500 LC/MS/MS System
购买 AB Sciex Qtrap 6500 LC/MS/MS 系统
  • 批准号:
    8824667
  • 财政年份:
    2015
  • 资助金额:
    $ 34.38万
  • 项目类别:
The Vanderbilt Molecular Target Discovery and Development Center
范德比尔特分子靶标发现和开发中心
  • 批准号:
    7944019
  • 财政年份:
    2009
  • 资助金额:
    $ 34.38万
  • 项目类别:
The Vanderbilt Molecular Target Discovery and Development Center
范德比尔特分子靶标发现和开发中心
  • 批准号:
    7853119
  • 财政年份:
    2009
  • 资助金额:
    $ 34.38万
  • 项目类别:
Imaging Tumor Expression of Cyclooxygenase-2
Cyclooxygenase-2 的肿瘤表达成像
  • 批准号:
    7490266
  • 财政年份:
    2008
  • 资助金额:
    $ 34.38万
  • 项目类别:
Integrative Training in Therapeutic Discovery
治疗发现的综合培训
  • 批准号:
    7224974
  • 财政年份:
    2006
  • 资助金额:
    $ 34.38万
  • 项目类别:
Integrative Training in Therapeutic Discovery
治疗发现的综合培训
  • 批准号:
    7668501
  • 财政年份:
    2006
  • 资助金额:
    $ 34.38万
  • 项目类别:
Integrative Training in Therapeutic Discovery
治疗发现的综合培训
  • 批准号:
    7492904
  • 财政年份:
    2006
  • 资助金额:
    $ 34.38万
  • 项目类别:
CHEMISTRY AND PHARMACOLOGY OF GLYCERYL PROSTAGLANDINS
甘油基前列腺素的化学和药理学
  • 批准号:
    7209624
  • 财政年份:
    2006
  • 资助金额:
    $ 34.38万
  • 项目类别:
Project 3: Cellular Effects of Aldehydic Products of Lipid Peroxidation
项目3:脂质过氧化醛产物的细胞效应
  • 批准号:
    8106389
  • 财政年份:
    2005
  • 资助金额:
    $ 34.38万
  • 项目类别:
Project 3: Cellular Effects of Aldehydic Products of Lipid Peroxidation
项目3:脂质过氧化醛产物的细胞效应
  • 批准号:
    7882605
  • 财政年份:
    2005
  • 资助金额:
    $ 34.38万
  • 项目类别:

相似海外基金

Biotin Orthogonal Streptavidin System (BOSS) for Drug Pre-Targeting
用于药物预靶向的生物素正交链霉亲和素系统 (BOSS)
  • 批准号:
    10606180
  • 财政年份:
    2023
  • 资助金额:
    $ 34.38万
  • 项目类别:
2023 RNA Nanotechnology Gordon Research Conference and Seminar
2023年RNA纳米技术戈登研究会议暨研讨会
  • 批准号:
    10598881
  • 财政年份:
    2023
  • 资助金额:
    $ 34.38万
  • 项目类别:
Mechanisms of mutant p53 reactivation
突变体 p53 重新激活的机制
  • 批准号:
    10719196
  • 财政年份:
    2023
  • 资助金额:
    $ 34.38万
  • 项目类别:
Development and Production of Standardized Reference Diets for Zebrafish Research
斑马鱼研究标准化参考饲料的开发和生产
  • 批准号:
    10823702
  • 财政年份:
    2023
  • 资助金额:
    $ 34.38万
  • 项目类别:
A Diet Intervention Study To Mitigate Fatigue Symptoms And To Improve Muscle And Physical Function In Older Adults With Post-Acute COVID-19 Syndrome
一项饮食干预研究,旨在减轻患有急性后 COVID-19 综合症的老年人的疲劳症状并改善肌肉和身体功能
  • 批准号:
    10734981
  • 财政年份:
    2023
  • 资助金额:
    $ 34.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了